Investor Stock List
Ranked #3,090 of 8,699 institutional investors

Johnson & Johnson

New Brunswick, NJ

$657M
US stock portfolio at live prices · today −$6.9M (−1.05%)
Market closed. Prices as of Nov 20, 5:41 AM ET
Value at quarter end (Q3 2026)
$762M
Change from Q2 2026
−$37.0M (−4.63%)
Positions
14 · 0 new, 0 sold out
Filed
Oct 26, 2026

Not counted in the ranking: none$73.1M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PTGX 46.2%NBTX 23.4%RAPP 6.41%XNCR 3.87%CTNM 2.72%
StockSharesValue, live% of portfoliovs Q2 2026
PTGX Protagonist Therapeutics, Inc.2,449,183$304M46.2%Unchanged
NBTX Nanobiotix S.A.5,623,816$154M23.4%Unchanged
RAPP Rapport Therapeutics, Inc.1,784,517$42.1M6.41%Unchanged
XNCR Xencor, Inc.748,062$25.4M3.87%Unchanged
CTNM Contineum Therapeutics, Inc.1,979,173$17.9M2.72%Unchanged
LEGN Legend Biotech Corporation814,586$13.1M2.00%Unchanged
CBRS Cerebras Systems Inc.128,649$11.2M1.70%Added +140%
PRCT PROCEPT BioRobotics Corporation357,939$9.2M1.40%Unchanged
FATE Fate Therapeutics, Inc.3,379,064$3.4M0.52%Unchanged
CVRX CVRx, Inc.4,024,861$2.1M0.33%Unchanged
VOR Vor Biopharma Inc.53,732$995K0.15%Unchanged
NMRA Neumora Therapeutics, Inc.1,849,445$642K<0.1%Unchanged
LAB Standard BioTools Inc.311,967$192K<0.1%Unchanged
ACET Adicet Bio, Inc.22,779$56K<0.1%Unchanged